Shawn Singh Vista Gen Therapeutics, Inc. (VTGN) insider trading activity
Shawn Singh is President and CEO of VistaGen Therapeutics, Inc.. Currently has a direct ownership of 18,028 shares of VTGN, which is worth approximately $45,791. The most recent transaction as insider was on Jun 30, 2025, when has been sold 7,541 shares (Common Stock) at a price of $1.7 per share, resulting in proceeds of $12,819. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18K
71.91%
3M change
71.91%
12M change
Total Value Held
$45,791
Shawn Singh Transaction History
SS
Shawn Singh
President and CEO
South San Francisco, CA